Company intelligence / Profile preview

Aescuven Pharma

Baden-Baden, Baden-Württemberg, Germany

Ownership: Private
Development stage: Other

Overview

Aescuven demonstrates robust efficacy for symptoms related to chronic venous insufficiency, with nearly one billion tablets sold annually in China and widespread market leadership in vein care. It is considered a trusted herbal remedy by both consumers and healthcare professionals. Clinical results show improved vascular tone, reduced inflammation, and symptom relief in chronic venous conditions.

Therapeutic areas: CardiovascularGastroenterology
Modalities: Small moleculeHerbal compound
Industry: Biotech

Partnerships

Likely collaborations with research institutions to validate efficacy

Beyond the preview

Go deeper on Aescuven Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aescuven Pharma.

Explore the full profile